Results 21 to 30 of about 45 (38)

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
Michael Manns
exaly  

Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C

Advanced Drug Delivery Reviews, 2002
K Rajender Reddy
exaly  

Physico-chemical properties and thermal stability of microcrystalline cellulose isolated from Alfa fibres

Carbohydrate Polymers, 2014
Djalal Trache, Kamel Khimeche, Nicolas Brosse   +2 more
exaly  

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

Kidney International, 2004
Michael Jones
exaly  

A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

Clinical Therapeutics, 2003
Lee S Schwartzberg
exaly  

Nanofibrillated cellulose from Alfa, Eucalyptus and Pine fibres: Preparation, characteristics and reinforcing potential

Carbohydrate Polymers, 2011
Manuel Rei Vilar, Sami Boufi
exaly  

Comparison of effects of darbepoetin alfa and epoetin alfa on serum endothelin level and blood pressure

Advances in Therapy, 2007
Mehmet Kanbay, Tuncay Delibasi, Faruk Turgut   +2 more
exaly  

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Lancet, The, 2007
Bernard Escudier, Alain Ravaud, Sergio Bracarda   +2 more
exaly  

Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

American Journal of Health-System Pharmacy, 2005
Jon D Herrington
exaly  

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

New England Journal of Medicine, 2009
Mitchell N Davis, Mark S Sulkowski
exaly